Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adherence to Endocrine Therapy and Racial Outcome Disparities in Breast Cancer
Katherine E. Reeder‐Hayes, Melissa A. Troester, Stephanie B. Wheeler
The Oncologist (2021) Vol. 26, Iss. 11, pp. 910-915
Open Access | Times Cited: 17

Showing 17 citing articles:

Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor–Positive, Node-Negative Breast Cancer
Olga Kantor, Tari A. King, Rachel A. Freedman, et al.
JAMA Surgery (2023) Vol. 158, Iss. 6, pp. 583-583
Open Access | Times Cited: 22
Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors
Carolyn Brandt, Jacqueline B. Vo, Gretchen L. Gierach, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 6, pp. 996-1006
Closed Access | Times Cited: 3
Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis
Juliana M. Torres, Michelle O. Sodipo, Margaret Hopkins, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 3
Geographic and sociodemographic access to systemic anticancer therapies for secondary breast cancer: a systematic review
Sally Anne Pearson, Sally Taylor, Antonia Marsden, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta‐analysis
Shaimaa Elshafie, Rupal Trivedi, Lorenzo Villa‐Zapata, et al.
Cancer (2024)
Open Access | Times Cited: 2
Motivational Interviewing Counseling to Increase Endocrine Therapy Adherence in Diverse Patients
Stephanie B. Wheeler, Jennifer C. Spencer, Sarah Drier, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1973-1973
Open Access | Times Cited: 6
Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
Seongwoo Yang, Seong Won Park, Soong June Bae, et al.
Journal of Breast Cancer (2023) Vol. 26, Iss. 4, pp. 309-309
Open Access | Times Cited: 4
Simulating the population impact of interventions to reduce racial gaps in breast cancer treatment
Juan Yanguela, Bradford E. Jackson, Katherine E. Reeder‐Hayes, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 6, pp. 902-910
Closed Access | Times Cited: 1
Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer
Sarah C. Van Alsten, Sanah Vohra, Joannie M. Ivory, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 1
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer
Shoshana M. Rosenberg, Yue Zheng, Shari Gelber, et al.
Breast Cancer Research and Treatment (2022) Vol. 197, Iss. 3, pp. 547-558
Open Access | Times Cited: 7
Leveraging Electronic Health Records to Address Breast Cancer Disparities
Solange Bayard, Genevieve A. Fasano, Rulla M. Tamimi, et al.
Current Breast Cancer Reports (2022) Vol. 14, Iss. 4, pp. 199-204
Open Access | Times Cited: 4
Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2−), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health
Ana-Alicia Beltran-Bless, Terry L. Ng
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1416-1416
Open Access | Times Cited: 3
Barriers to endocrine therapy adherence: perspectives of Black breast cancer survivors and their providers
Kimberley Lee, Brian D. Gonzalez, Carley Geiss, et al.
Journal of Cancer Survivorship (2024)
Open Access
Racial Disparities in Locoregional Recurrence in Postmenopausal Patients with Stage I–III, Hormone Receptor-Positive Breast Cancer Enrolled in the NSABP B-42 Clinical Trial
Charity C. Glass, Robert M. Pride, Rachel A. Freedman, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 13, pp. 8320-8326
Closed Access | Times Cited: 1
Reduced racial disparity in receipt of optimal locoregional treatment for women with early-stage breast cancer
Hasan Nadeem, John A. Romley, Shaneda Warren Andersen
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291025-e0291025
Open Access
Silent suffering: the impact of sexual health challenges on patient-clinician communication and adherence to adjuvant endocrine therapy among Black women with early-stage breast cancer
Janeane N. Anderson, Andrew J. Paladino, Ryan Blue, et al.
Journal of Cancer Survivorship (2023)
Closed Access
The impact of geographical and sociodemographic variation on access to Systemic Anti- Cancer Therapies for Secondary Breast Cancer: A systematic review
Sally Anne Pearson, Sally Taylor, Antonia Marsden, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top